Sign In
Buy SAN
$12.47
+0.310 (+2.55%)
At Close: Jun 04, 2026
Santander Bank Debuts Santander eLockBox to Consolidate Digital Payments
03:38pm, Wednesday, 13'th Apr 2022
Banking giant Santander Bank, N.A. on Wednesday (April 13) launched Santander eLockBox, an electronic lockbox that consolidates businesses' incoming digital payments and simplifies electronic receivab
Sanofi - AGM 03.05.2022 - Availability of Preparatory Documents
04:25pm, Tuesday, 12'th Apr 2022 GlobeNewswire Inc.
COMBINED GENERAL MEETING OF MAY 3, 2022
Sanofi - AGM 03.05.2022 - Mise à disposition des documents préparatoires
04:25pm, Tuesday, 12'th Apr 2022 GlobeNewswire Inc.
ASSEMBLEE GENERALE MIXTE DU 3 MAI 2022
Communiqué de presse: La Commission européenne approuve Dupixent® (dupilumab) pour le traitement des enfants âgés de 6 à 11 ans présentant un asthme sévère avec signature inflammatoire de type 2
05:00am, Thursday, 07'th Apr 2022 GlobeNewswire Inc.
La Commission européenne approuve Dupixent® (dupilumab) pour le traitement des enfants âgés de 6 à 11 ans présentant un asthme sévère avec signature inflammatoire de type 2
Press Release: Dupixent® (dupilumab) approved by European Commission for children aged 6 to 11 years with severe asthma with type 2 inflammation
05:00am, Thursday, 07'th Apr 2022 GlobeNewswire Inc.
Dupixent® (dupilumab) approved by European Commission for children aged 6 to 11 years with severe asthma with type 2 inflammation
Communiqué de presse: La FDA accepte d’accorder un examen prioritaire à Dupixent® (dupilumab) pour le traitement des patients de 12 ans et plus souffrant d’œsophagite à éosinophiles
05:00am, Monday, 04'th Apr 2022 GlobeNewswire Inc.
La FDA accepte d’accorder un examen prioritaire à Dupixent® (dupilumab) pour le traitement des patients de 12 ans et plus souffrant d’œsophagite à éosinophiles
Press Release: FDA accepts Dupixent® (dupilumab) for Priority Review in patients aged 12 years and older with eosinophilic esophagitis
05:00am, Monday, 04'th Apr 2022 GlobeNewswire Inc.
FDA accepts Dupixent® (dupilumab) for Priority Review in patients aged 12 years and older with eosinophilic esophagitis
Benzinga's Top Ratings Upgrades, Downgrades For April 1, 2022
02:17pm, Friday, 01'st Apr 2022 Benzinga
Upgrades
For Banco Santander SA (NYSE:SAN), Credit Suisse upgraded the previous rating of Neutral to Outperform. Banco Santander earned $0.14 in the fourth quarter, compared to $0.09 in the year-ago q
Santander's 2022 targets on track as Americas help
06:29am, Friday, 01'st Apr 2022
Spain's Santander on Friday said it was on track to meet its 2022 profitability target and maintained its mid-term goals thanks to solid performance in the Americas and a recovery in Europe.
Press Release: EUROAPI listing on Euronext Paris expected on May 6, 2022
05:30am, Friday, 01'st Apr 2022 GlobeNewswire Inc.
Communiqué de presse : Cotation d’EUROAPI sur Euronext Paris prévue le 6 mai 2022
05:30am, Friday, 01'st Apr 2022 GlobeNewswire Inc.
Press Release: Sanofi successfully priced an inaugural sustainability-linked bond indexed on access to medicines
05:00am, Thursday, 31'st Mar 2022 GlobeNewswire Inc.
Communiqué de presse : Sanofi lance avec succès une émission obligataire indexée sur l’accès aux médicaments
05:00am, Thursday, 31'st Mar 2022 GlobeNewswire Inc.
Communiqué de presse : Mise en ligne du document «Q1 2022 Memorandum for modelling purposes»
05:30am, Wednesday, 30'th Mar 2022 GlobeNewswire Inc.
